Cat chronic kidney disease (CKD) affects approximately 10 million cats worldwide, and many are diagnosed at stages 3–4, requiring long-term subcutaneous fluid therapy at home. By integrating the infusion workflow with stable guidance, LUMO reduces the risks and psychological stress of solo caregiving, enabling safer and more sustainable home care while improving cats’ quality of life.
